SiNtx Technologies Is Maintained at Buy by Ascendiant Capital
SINTX Technologies Analyst Ratings
Express News | SINTX Technologies Inc : Ascendiant Capital Markets Cuts Target Price to $30 From $70
Maxim Group Maintains Sintx Technologies(SINT.US) With Hold Rating
Sintx Technologies Files to Sell 3.01M Shares of Common Stock for Holders
Sintx Technologies | 10-K: FY2024 Annual Report
SINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine Fusion
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Sintx Technologies Names CEO Eric Olson Chairman, Succeeding Sonny Bal; Stock Down
Sintx Technologies Announces Board Chairman Transition
SiNtx Technologies Sonny Bal Retires as Chmn of the Bd >SINT
Express News | SINTX Technologies Inc: B. Sonny Bal Stepped Down as Chairman of Board and Continues to Serve on Company's Board of Directors
Express News | SINTX Technologies Inc: On March 7, Appointed Eric K. Olson to Position of Chairman of Board of Directors
Why SINTX Technologies Stock Is Down 21%
Express News | SiNtx Technologies Shares Are Trading Lower After the Company Announced a $5 Million Private Placement
Express News | SINTX Technologies Announces $5 Million Private Placement Priced at-the-Market Under Nasdaq Rules
SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Express News | SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market
Express News | SINTX Technologies Inc - Enters Entity Acquisition Agreement With Tethon
SINTX Technologies SINT +70% Patent; CNS Pharmaceuticals CNSP -41% Reverse Split